[ABMD] ABIOMED, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization: 5.06 B

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 112.38 Change: 0.83 (0.74%)
Ext. hours: Change: 0 (0%)

chart ABMD

Refresh chart

Strongest Trends Summary For ABMD

ABMD is in the long-term up 1119% in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart fai

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding42.99 M EPS1.16 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 38.41% Sales Growth - Q/Q8.95% P/E123.61
P/E To EPS Growth P/S21.98 P/BV17.37 Price/Cash Per Share38.37
Price/Free Cash Flow132.89 ROA33.6% ROE38.99% ROI
Current Ratio5.6 Quick Ratio5.17 Long Term Debt/Equity Debt Ratio0.13
Gross Margin82.66% Operating Margin12.45% Net Profit Margin49.36% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities9.52 M Cash From Investing Activities-49.86 M Cash From Operating Activities43.29 M Gross Profit56.75 M
Net Profit98.87 M Operating Profit12.36 M Total Assets338.37 M Total Current Assets220.14 M
Total Current Liabilities39.32 M Total Debt Total Liabilities46.81 M Total Revenue67.56 M
Technical Data
High 52 week446.21 Low 52 week170.55 Last close260.48 Last change-0.63%
RSI38.18 Average true range12.1 Beta1.14 Volume141.67 K
Simple moving average 20 days-1.81% Simple moving average 50 days-8.37% Simple moving average 200 days-16.62%
Performance Data
Performance Week0.6% Performance Month3.57% Performance Quart-28.06% Performance Half-11.16%
Performance Year48% Performance Year-to-date-35.84% Volatility daily1.9% Volatility weekly4.24%
Volatility monthly8.69% Volatility yearly30.11% Relative Volume291.59% Average Volume739.39 K
New High New Low

News

2019-11-14 09:59:00 | Clinical Review Demonstrates Cost-Effectiveness of Impella in High-Risk PCI and Cardiogenic Shock

2019-11-12 07:05:00 | Lawsuit for Investors in Abiomed, Inc. NASDAQ: ABMD shares announced by Shareholders Foundation

2019-11-11 18:40:49 | Edited Transcript of ABMD earnings conference call or presentation 31-Oct-19 12:00pm GMT

2019-11-08 14:18:04 | 3 Former Growth Stocks to Consider Buying Again

2019-11-05 06:20:02 | What Is Abiomed's NASDAQ:ABMD P/E Ratio After Its Share Price Rocketed?

2019-10-31 18:58:07 | US Stocks Tumble Thursday

2019-10-31 10:09:02 | Impressive Near-Term Outlook for Medical Instruments Industry

2019-10-31 09:01:01 | ABIOMED ABMD Earnings Beat, Revenues Miss Estimates in Q2

2019-10-31 08:15:12 | Abiomed ABMD Q2 Earnings Top Estimates

2019-10-31 07:02:00 | First U.S. Patients Treated with Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump

2019-10-31 07:00:00 | Abiomed Announces Q2 FY 2020 Revenue of $205 Million and 29.4% Operating Margin

2019-10-31 06:00:00 | ABIOMED, Inc. to Host Earnings Call

2019-10-30 12:44:29 | Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More

2019-10-29 13:00:13 | 12 Stocks With The Highest Returns On Assets

2019-10-26 09:15:00 | CORRECTING and REPLACING CAPTION FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival

2019-10-25 10:25:02 | ABIOMED ABMD to Report Q2 Earnings: What's in the Offing?

2019-10-25 09:55:00 | CORRECTING and REPLACING GRAPHIC FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival

2019-10-24 10:32:02 | Abiomed ABMD Earnings Expected to Grow: Should You Buy?

2019-10-23 15:26:04 | 16 Stocks With The Highest Long-Term Sales Growth Rate

2019-10-22 06:01:04 | Do You Know What Abiomed, Inc.'s NASDAQ:ABMD P/E Ratio Means?

2019-10-21 11:28:13 | Cramer Advises His Viewers On Beyond Meat, Texas Instruments And More

2019-10-20 15:18:26 | Hedge Funds Aren’t Crazy About ABIOMED, Inc. ABMD Anymore

2019-10-14 12:08:25 | 7 Under-The-Radar Growth Stocks That Could Benefit New Investors

2019-10-11 15:20:27 | Wall Street Rallies Friday

2019-10-10 15:55:00 | Abiomed Second Quarter Fiscal 2020 Earnings and Conference Call Notification

2019-10-08 10:04:02 | AngioDynamics Boosts VIT Product Portfolio With New Buyout

2019-10-07 12:20:00 | CLASS ACTION UPDATE for ABMD, WTRH and MYGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-10-07 10:40:00 | MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abiomed, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-10-07 10:08:00 | FINAL DEADLINE ALERT - Abiomed, Inc. ABMD - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Deadline: October 7, 2019

2019-10-07 09:40:30 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABMD, EVH, WTRH and MYGN

2019-10-07 08:00:00 | Abiomed Announces 1,000th Patient Treated with Impella in Japan

2019-10-06 14:30:00 | ROSEN, A LEADING LAW FIRM, Reminds Abiomed, Inc. Investors of Important October 7th Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ABMD

2019-10-06 10:46:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABMD, CVS and CADE

2019-10-04 20:35:00 | FINAL DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abiomed, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm

2019-10-04 15:50:00 | SHAREHOLDER ALERT: CURLF ABMD OSTK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-10-04 15:00:00 | SHAREHOLDER ALERT - Abiomed, Inc. ABMD - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Deadline: October 7, 2019

2019-10-04 10:15:00 | The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABMD, EVH and VAL

2019-10-04 10:05:00 | ABMD, IFF & GVA - Class Action Update - Bronstein, Gewirtz & Grossman, LLC

2019-10-04 09:02:00 | ABIOMED DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In ABIOMED, Inc. To Contact The Firm

2019-10-03 12:30:00 | SHAREHOLDER ALERT: ABMD FTCH OLLI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

2019-10-03 11:00:00 | Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Abiomed, Inc.

2019-10-03 10:58:02 | Luminex Gets FDA Nod for ARIES MRSA Assay, Boosts Platform

2019-10-03 10:58:00 | ABIOMED SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In ABIOMED, Inc. To Contact The Firm

2019-10-03 10:52:45 | Zhang Investor Law Reminds Investors of October 7 Deadline in Securities Class Action Lawsuit Against Abiomed, Inc. – ABMD

2019-10-03 10:26:40 | CLASS ACTION UPDATE for ABMD, TXT, MDP and FTCH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2019-10-02 22:15:00 | 5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abiomed, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm

2019-10-02 13:45:00 | The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ABMD, IFF and VRAY

2019-10-02 12:02:00 | ABIOMED DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In ABIOMED, Inc. To Contact The Firm

2019-10-02 12:00:41 | 3 Pharma Stocks at Risk for Downgrades

2019-10-02 10:45:00 | CLASS ACTION UPDATE for ABMD, SNDL and CADE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders